Heo Y[au] - Search Results

Year	Number of Results
1987	1
1990	1
1994	1
1996	1
1997	2
1998	2
1999	1
2000	1
2001	5
2002	10
2003	8
2004	11
2005	15
2006	11
2007	11
2008	24
2009	34
2010	49
2011	43
2012	35
2013	48
2014	53
2015	59
2016	67
2017	64
2018	73
2019	86
2020	97
2021	116
2022	39

1

Voclosporin: First Approval.

Heo YA. Heo YA. Drugs. 2021 Apr;81(5):605-610. doi: 10.1007/s40265-021-01488-z. Drugs. 2021. PMID: 33788181 Free PMC article. Review.

2

Golodirsen: First Approval.

Heo YA. Heo YA. Drugs. 2020 Feb;80(3):329-333. doi: 10.1007/s40265-020-01267-2. Drugs. 2020. PMID: 32026421 Review.

3

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.

Heo YA, Syed YY, Keam SJ. Heo YA, et al. Drugs. 2019 May;79(7):767-777. doi: 10.1007/s40265-019-01120-1. Drugs. 2019. PMID: 31030380 Free PMC article. Review.

4

Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections.

Heo YA. Heo YA. Drugs. 2021 Feb;81(3):377-388. doi: 10.1007/s40265-021-01471-8. Epub 2021 Feb 25. Drugs. 2021. PMID: 33630278 Free PMC article. Review.

5

A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.

Yoo HC, Park SJ, Nam M, Kang J, Kim K, Yeo JH, Kim JK, Heo Y, Lee HS, Lee MY, Lee CW, Kang JS, Kim YH, Lee J, Choi J, Hwang GS, Bang S, Han JM. Yoo HC, et al. Among authors: heo y. Cell Metab. 2020 Feb 4;31(2):267-283.e12. doi: 10.1016/j.cmet.2019.11.020. Epub 2019 Dec 19. Cell Metab. 2020. PMID: 31866442 Free article.

6

TFEB-GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response.

Kim J, Kim SH, Kang H, Lee S, Park SY, Cho Y, Lim YM, Ahn JW, Kim YH, Chung S, Choi CS, Jang YJ, Park HS, Heo Y, Kim KH, Lee MS. Kim J, et al. Among authors: heo y. Nat Metab. 2021 Mar;3(3):410-427. doi: 10.1038/s42255-021-00368-w. Epub 2021 Mar 22. Nat Metab. 2021. PMID: 33758420

7

Efgartigimod: First Approval.

Heo YA. Heo YA. Drugs. 2022 Feb;82(3):341-348. doi: 10.1007/s40265-022-01678-3. Drugs. 2022. PMID: 35179720 Free PMC article. Review.

8

Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology.

Lee HT, Lee SH, Heo YS. Lee HT, et al. Among authors: heo ys. Molecules. 2019 Mar 26;24(6):1190. doi: 10.3390/molecules24061190. Molecules. 2019. PMID: 30917623 Free PMC article. Review.

9

Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.

Tsuji Y, Holford NHG, Kasai H, Ogami C, Heo YA, Higashi Y, Mizoguchi A, To H, Yamamoto Y. Tsuji Y, et al. Among authors: heo ya. Br J Clin Pharmacol. 2017 Aug;83(8):1758-1772. doi: 10.1111/bcp.13262. Epub 2017 Mar 31. Br J Clin Pharmacol. 2017. PMID: 28186644 Free PMC article.

10

Visfatin Induces Inflammation and Insulin Resistance via the NF-κB and STAT3 Signaling Pathways in Hepatocytes.

Heo YJ, Choi SE, Jeon JY, Han SJ, Kim DJ, Kang Y, Lee KW, Kim HJ. Heo YJ, et al. J Diabetes Res. 2019 Jul 17;2019:4021623. doi: 10.1155/2019/4021623. eCollection 2019. J Diabetes Res. 2019. PMID: 31396538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results